{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T22:40:59Z","timestamp":1793227259780,"version":"4.5.0"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","diabetesresearchclinicalpractice.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes Research and Clinical Practice"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.diabres.2022.109819","type":"journal-article","created":{"date-parts":[[2022,3,3]],"date-time":"2022-03-03T19:08:16Z","timestamp":1646334496000},"page":"109819","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Metabolic determinants of NAFLD in adults with type 1 diabetes"],"prefix":"10.1016","volume":"186","author":[{"given":"M.","family":"Serdarova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Dimova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Chakarova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Grozeva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Todorova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Tsarkova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Marinova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Popov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Mateva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Tankova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.diabres.2022.109819_b0005","doi-asserted-by":"crossref","unstructured":"Benedict M, Zhang X, Benedict M, Zhang X. Non-alcoholic fatty liver disease\u00a0: an expanded review 2017;9:715\u201332. doi: 10.4254\/wjh.v9.i16.715.","DOI":"10.4254\/wjh.v9.i16.715"},{"key":"10.1016\/j.diabres.2022.109819_b0010","doi-asserted-by":"crossref","DOI":"10.3390\/ijms17050774","article-title":"The natural course of non-alcoholic fatty liver disease","volume":"17","author":"Calzadilla Bertot","year":"2016","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.diabres.2022.109819_b0015","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.2337\/dc07-0349","article-title":"Nonalcoholic fatty liver disease is independently associated with an increased incidence of cardiovascular events in type 2 diabetic patients","volume":"30","author":"Targher","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2022.109819_b0020","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.3748\/wjg.v13.i10.1579","article-title":"Nonalcoholic fatty liver disease is a novel predictor of cardiovascular disease","volume":"13","author":"Hamaguchi","year":"2007","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.diabres.2022.109819_b0025","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1002\/hep.24356","article-title":"Fatty liver index and mortality: the Cremona study in the 15th year of follow-up","volume":"54","author":"Calori","year":"2011","journal-title":"Hepatology (Baltimore, MD)"},{"key":"10.1016\/j.diabres.2022.109819_b0030","doi-asserted-by":"crossref","first-page":"9330","DOI":"10.3748\/wjg.v20.i28.9330","article-title":"Non-alcoholic fatty liver disease and obesity: biochemical, metabolic and clinical presentations","volume":"20","author":"Mili\u0107","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.diabres.2022.109819_b0035","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1210\/er.2017-00191","article-title":"Obesity in Type 1 diabetes: pathophysiology, clinical impact, and mechanisms","volume":"39","author":"Corbin","year":"2018","journal-title":"Endocr Rev"},{"key":"10.1016\/j.diabres.2022.109819_b0040","doi-asserted-by":"crossref","unstructured":"Estes C, Razavi H, Loomba R, Younossi Z. Fatty liver disease demonstrates an exponential increase in burden of disease 2018;67:123\u201333. doi: 10.1002\/hep.29466.","DOI":"10.1002\/hep.29466"},{"key":"10.1016\/j.diabres.2022.109819_b0045","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.ijcard.2016.10.040","article-title":"Nonalcoholic fatty liver disease is independently associated with an increased incidence of cardiovascular disease in adult patients with type 1 diabetes","volume":"225","author":"Mantovani","year":"2016","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.diabres.2022.109819_b0050","doi-asserted-by":"crossref","first-page":"26805","DOI":"10.1038\/srep26805","article-title":"Nonalcoholic fatty liver disease is associated with increased carotid intima-media thickness in type 1 diabetic patients","volume":"6","author":"Zhang","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.diabres.2022.109819_b0055","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.2337\/dc13-2704","article-title":"Nonalcoholic fatty liver disease is independently associated with an increased incidence of chronic kidney disease in patients with type 1 diabetes","volume":"37","author":"Targher","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2022.109819_b0060","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/j.jdiacomp.2017.01.024","article-title":"Nonalcoholic fatty liver disease is associated with an increased prevalence of distal symmetric polyneuropathy in adult patients with type 1 diabetes","volume":"31","author":"Mantovani","year":"2017","journal-title":"J Diabetes Complications"},{"key":"10.1016\/j.diabres.2022.109819_b0065","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1111\/dom.12929","article-title":"Prevalence of elevated liver enzymes in adults with type 1 diabetes: a multicentre analysis of the German\/Austrian DPV database","volume":"19","author":"Stadler","year":"2017","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.diabres.2022.109819_b0070","doi-asserted-by":"crossref","first-page":"734","DOI":"10.2337\/dc06-1539","article-title":"Spectrum of liver disease in type 2 diabetes and management of patients with diabetes and liver disease","volume":"30","author":"Tolman","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2022.109819_b0075","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.cld.2015.10.006","article-title":"Clinical presentation and patient evaluation in nonalcoholic fatty liver disease","volume":"20","author":"Patel","year":"2016","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.diabres.2022.109819_b0080","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1053\/j.gastro.2017.03.017","article-title":"American gastroenterological association institute guideline on the role of elastography in the evaluation of liver fibrosis","volume":"152","author":"Lim","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.diabres.2022.109819_b0085","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/S1665-2681(19)31021-X","article-title":"Transient elastography in non-alcoholic fatty liver disease","volume":"11","author":"Abenavoli","year":"2012","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.diabres.2022.109819_b0090","first-page":"128","article-title":"Application of transient elastography in nonalcoholic fatty liver disease. Clinical and Molecular","volume":"26","author":"Zhang","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.diabres.2022.109819_b0095","doi-asserted-by":"crossref","first-page":"2390","DOI":"10.1007\/s00330-010-1820-9","article-title":"Transient elastography with a new probe for obese patients for non-invasive staging of non-alcoholic steatohepatitis","volume":"20","author":"Friedrich-Rust","year":"2010","journal-title":"Eur Radiol"},{"key":"10.1016\/j.diabres.2022.109819_b0100","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1111\/j.1478-3231.2010.02258.x","article-title":"Feasibility of liver transient elastography with FibroScan using a new probe for obese patients","volume":"30","author":"de L\u00e9dinghen","year":"2010","journal-title":"Liver Int: Official J Int Assoc Study Liver"},{"key":"10.1016\/j.diabres.2022.109819_b0105","doi-asserted-by":"crossref","unstructured":"Tuong TTK, Tran DK, Phu PQT, Hong TND, Dinh TC, Chu DT. Non-alcoholic fatty liver disease in patients with type 2 diabetes: evaluation of hepatic fibrosis and steatosis using fibroscan. Diagnostics (Basel, Switzerland) 2020;10. doi: 10.3390\/diagnostics10030159.","DOI":"10.3390\/diagnostics10030159"},{"key":"10.1016\/j.diabres.2022.109819_b0110","doi-asserted-by":"crossref","unstructured":"Alberti KGMM, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International. Circulation 2009;120:1640\u20135. doi: 10.1161\/CIRCULATIONAHA.109.192644.","DOI":"10.1161\/CIRCULATIONAHA.109.192644"},{"key":"10.1016\/j.diabres.2022.109819_b0115","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.diabet.2016.10.007","article-title":"Predictors of cardiovascular risk among patients with type 1 diabetes: a critical analysis of the metabolic syndrome and its components","volume":"43","author":"Gingras","year":"2017","journal-title":"Diabetes Metab"},{"key":"10.1016\/j.diabres.2022.109819_b0120","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.dld.2010.01.016","article-title":"From the metabolic syndrome to NAFLD or vice versa?","volume":"42","author":"Vanni","year":"2010","journal-title":"Dig Liver Dis: Official J Italian Soc Gastroenterol Italian Assoc Study Liver"},{"key":"10.1016\/j.diabres.2022.109819_b0125","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1002\/hep.25772","article-title":"Association between diabetes, family history of diabetes, and risk of nonalcoholic steatohepatitis and fibrosis","volume":"56","author":"Loomba","year":"2012","journal-title":"Hepatology (Baltimore, MD)"},{"key":"10.1016\/j.diabres.2022.109819_b0130","doi-asserted-by":"crossref","first-page":"63","DOI":"10.2337\/dc08-0472","article-title":"Effect of parental type 2 diabetes on offspring with type 1 diabetes","volume":"32","author":"Thorn","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2022.109819_b0135","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.cld.2015.10.002","article-title":"The metabolic syndrome and its influence on nonalcoholic steatohepatitis","volume":"20","author":"Kanwar","year":"2016","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.diabres.2022.109819_b0140","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.2174\/138161210791208875","article-title":"Insulin resistance in nonalcoholic fatty liver disease","volume":"16","author":"Bugianesi","year":"2010","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.diabres.2022.109819_b0145","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.1111\/dom.13848","article-title":"Double diabetes: a distinct high-risk group?","volume":"21","author":"Kietsiriroje","year":"2019","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.diabres.2022.109819_b0150","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.dld.2015.08.004","article-title":"Epidemiological modifiers of non-alcoholic fatty liver disease: Focus on high-risk groups","volume":"47","author":"Lonardo","year":"2015","journal-title":"Dig Liver Disease: Official J Italian Soc Gastroenterol Italian Assoc Study Liver"},{"key":"10.1016\/j.diabres.2022.109819_b0155","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000004293","article-title":"Association of blood pressure level with nonalcoholic fatty liver disease in nonhypertensive population: normal is not the new normal","volume":"95","author":"Qian","year":"2016","journal-title":"Medicine"},{"key":"10.1016\/j.diabres.2022.109819_b0160","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1097\/MEG.0b013e32834b8d52","article-title":"Nonalcoholic fatty liver disease is associated with blood pressure in hypertensive and nonhypertensive individuals from the general population with normal levels of alanine aminotransferase","volume":"23","author":"L\u00f3pez-Su\u00e1rez","year":"2011","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.diabres.2022.109819_b0165","doi-asserted-by":"crossref","first-page":"6571","DOI":"10.3748\/wjg.v23.i36.6571","article-title":"Nonalcoholic fatty liver disease: evolving paradigms","volume":"23","author":"Lonardo","year":"2017","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.diabres.2022.109819_b0170","doi-asserted-by":"crossref","first-page":"707","DOI":"10.2337\/dc06-1982","article-title":"Insulin resistance, the metabolic syndrome, and complication risk in type 1 diabetes: \u201cdouble diabetes\u201d in the Diabetes Control and Complications Trial","volume":"30","author":"Kilpatrick","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2022.109819_b0175","doi-asserted-by":"crossref","unstructured":"EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease. J Hepatol 2016;64:1388\u2013402. doi: 10.1016\/j.jhep.2015.11.004.","DOI":"10.1016\/j.jhep.2015.11.004"},{"key":"10.1016\/j.diabres.2022.109819_b0180","doi-asserted-by":"crossref","unstructured":"AISF position paper on nonalcoholic fatty liver disease (NAFLD): Updates and future directions. Dig Liver Dis: Official J Italian Soc Gastroenterol Italian Assoc Study Liver 2017;49:471\u201383. doi: 10.1016\/j.dld.2017.01.147.","DOI":"10.1016\/j.dld.2017.01.147"},{"key":"10.1016\/j.diabres.2022.109819_b0185","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.3748\/wjg.v21.i5.1650","article-title":"Central obesity and nonalcoholic fatty liver disease risk after adjusting for body mass index","volume":"21","author":"Pang","year":"2015","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.diabres.2022.109819_b0190","doi-asserted-by":"crossref","first-page":"4788","DOI":"10.1038\/s41598-018-23192-x","article-title":"Waist circumference is a mediator of dietary pattern in non-alcoholic fatty liver disease","volume":"8","author":"Ghaemi","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.diabres.2022.109819_b0195","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1900\/RDS.2011.8.454","article-title":"Hepatic steatosis in type 1 diabetes","volume":"8","author":"Regnell","year":"2011","journal-title":"Rev Diabetic Stud: RDS"},{"key":"10.1016\/j.diabres.2022.109819_b0200","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1053\/j.gastro.2007.04.068","article-title":"Relationship between hepatic\/visceral fat and hepatic insulin resistance in nondiabetic and type 2 diabetic subjects","volume":"133","author":"Gastaldelli","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.diabres.2022.109819_b0205","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1053\/j.gastro.2008.03.021","article-title":"Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes","volume":"135","author":"Kotronen","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.diabres.2022.109819_b0210","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.2337\/diabetes.54.6.1684","article-title":"Glucose-stimulated upregulation of GLUT2 gene is mediated by sterol response element-binding protein-1c in the hepatocytes","volume":"54","author":"Im","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.diabres.2022.109819_b0215","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1111\/dom.12973","article-title":"Non-alcoholic fatty liver disease (NAFLD) prevalence and its metabolic associations in patients with type 1 diabetes and type 2 diabetes","volume":"19","author":"Cusi","year":"2017","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.diabres.2022.109819_b0220","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1210\/jc.2014-3050","article-title":"Liver fat content and hepatic insulin sensitivity in overweight patients with type 1 diabetes","volume":"100","author":"Llaurad\u00f3","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.diabres.2022.109819_b0225","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1007\/BF00274790","article-title":"Enhanced hepatic insulin sensitivity, but peripheral insulin resistance in patients with type 1 (insulin-dependent) diabetes","volume":"30","author":"Hother-Nielsen","year":"1987","journal-title":"Diabetologia"},{"key":"10.1016\/j.diabres.2022.109819_b0230","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1007\/s00125-005-0132-0","article-title":"Insulin glargine or NPH combined with metformin in type 2 diabetes: the LANMET study","volume":"49","author":"Yki-J\u00e4rvinen","year":"2006","journal-title":"Diabetologia"},{"key":"10.1016\/j.diabres.2022.109819_b0235","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1161\/ATVBAHA.107.147538","article-title":"Fatty liver: a novel component of the metabolic syndrome","volume":"28","author":"Kotronen","year":"2008","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.diabres.2022.109819_b0240","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.cld.2015.10.005","article-title":"The prevalence and pathobiology of nonalcoholic fatty liver disease in patients of different races or ethnicities","volume":"20","author":"Kalia","year":"2016","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.diabres.2022.109819_b0245","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/ajg.2016.318","article-title":"Clinical and metabolic characterization of lean caucasian subjects with non-alcoholic fatty liver","volume":"112","author":"Feldman","year":"2017","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.diabres.2022.109819_b0250","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1007\/s00125-005-1682-x","article-title":"Insulin resistance in non-diabetic patients with non-alcoholic fatty liver disease: sites and mechanisms","volume":"48","author":"Bugianesi","year":"2005","journal-title":"Diabetologia"},{"key":"10.1016\/j.diabres.2022.109819_b0255","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1001\/archinte.164.19.2169","article-title":"Metabolic significance of nonalcoholic fatty liver disease in nonobese, nondiabetic adults","volume":"164","author":"Kim","year":"2004","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.diabres.2022.109819_b0260","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/MD.0b013e3182779d49","article-title":"Nonalcoholic fatty liver disease in lean individuals in the United States","volume":"91","author":"Younossi","year":"2012","journal-title":"Medicine"},{"key":"10.1016\/j.diabres.2022.109819_b0265","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1002\/hep.20466","article-title":"Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity","volume":"40","author":"Browning","year":"2004","journal-title":"Hepatology (Baltimore, MD)"},{"key":"10.1016\/j.diabres.2022.109819_b0270","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1055\/s-0035-1562943","article-title":"Epidemiology and natural history of nonalcoholic fatty liver disease","volume":"35","author":"Satapathy","year":"2015","journal-title":"Semin Liver Dis"}],"container-title":["Diabetes Research and Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822722006313?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822722006313?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T19:20:31Z","timestamp":1759173631000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168822722006313"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":54,"alternative-id":["S0168822722006313"],"URL":"https:\/\/doi.org\/10.1016\/j.diabres.2022.109819","relation":{},"ISSN":["0168-8227"],"issn-type":[{"value":"0168-8227","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metabolic determinants of NAFLD in adults with type 1 diabetes","name":"articletitle","label":"Article Title"},{"value":"Diabetes Research and Clinical Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diabres.2022.109819","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109819"}}